The Interaction between Enterobacteriaceae and Calcium Oxalate Deposits

Evan Barr-Beare, Vijay Saxena, Evann E Hilt, Krystal Thomas-White, Megan Schober, Birong Li, Brian Becknell, David S Hains, Alan J Wolfe, Andrew L Schwaderer, Evan Barr-Beare, Vijay Saxena, Evann E Hilt, Krystal Thomas-White, Megan Schober, Birong Li, Brian Becknell, David S Hains, Alan J Wolfe, Andrew L Schwaderer

Abstract

Background: The role of calcium oxalate crystals and deposits in UTI pathogenesis has not been established. The objectives of this study were to identify bacteria present in pediatric urolithiasis and, using in vitro and in vivo models, to determine the relevance of calcium oxalate deposits during experimental pyelonephritis.

Methods: Pediatric kidney stones and urine were collected and both cultured and sequenced for bacteria. Bacterial adhesion to calcium oxalate was compared. Murine kidney calcium oxalate deposits were induced by intraperitoneal glyoxalate injection and kidneys were transurethrally inoculated with uropathogenic Escherichia coli to induce pyelonephritis.

Results: E. coli of the family Enterobacteriaceae was identified in patients by calcium oxalate stone culture. Additionally Enterobacteriaceae DNA was sequenced from multiple calcium oxalate kidney stones. E. coli selectively aggregated on and around calcium oxalate monohydrate crystals. Mice inoculated with glyoxalate and uropathogenic E. coli had higher bacterial burdens, increased kidney calcium oxalate deposits and an increased kidney innate immune response compared to mice with only calcium oxalate deposits or only pyelonephritis.

Conclusions: In a murine model, the presence of calcium oxalate deposits increases pyelonephritis risk, likely due to preferential aggregation of bacteria on and around calcium oxalate crystals. When both calcium oxalate deposits and uropathogenic bacteria were present, calcium oxalate deposit number increased along with renal gene transcription of inner stone core matrix proteins increased. Therefore renal calcium oxalate deposits may be a modifiable risk factor for infections of the kidney and urinary tract. Furthermore, bacteria may be present in calcium oxalate deposits and potentially contribute to calcium oxalate renal disease.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Induction of CaOx deposits and…
Fig 1. Induction of CaOx deposits and experimental pyelonephritis in mice.
Fig 2. Kidney stones contain bacteria and/or…
Fig 2. Kidney stones contain bacteria and/or DNA.
(A) Bacteria key. (B) All stones contained multiple bacterial taxa on sequencing (left column) Bacteria identified included the family Enterobacteriaceae (which includes E. coli), and the genera Pseudomonas, Gardnerella, Lactobacillus, Brucella, Phyllobacterium and Bradyrhizobium. Bacteria were cultured (right column) from 2 stones and represented the most abundant bacteria identified by sequencing. (C) Bacteria were only sequenced and cultured from upper tract urine in 1 patient. (D) When detected in the bladder urine, the taxa were similar to those observed in the stones, although the ratios were often dissimilar. To allow low percentage organisms to be visualized, the data was graphed on a logarithmic Y-axis.
Fig 3. UPEC selectively aggregate around CaOx…
Fig 3. UPEC selectively aggregate around CaOx monohydrate crystals: following incubation with GFP labeled UPEC, bacteria (green) could be seen aggregating around CaOx monohydrate (A, arrows) but not CaOx dihydrate (A, arrowheads) or silicon dioxide (B, arrows) crystals.
At 12 hours, significantly more bacteria per crystal surface area were seen with CaOx monohydrate crystals than with CaOx dihydrate crystals, silicon dioxide crystals or background. There were no other significant differences between groups. Magnification 40X right panels, 100X left panels Scale bars = 20 microns. Incubation time = 6 hours for left panels and 12 hours for right panels.
Fig 4. Bacteria increases the murine CaOx…
Fig 4. Bacteria increases the murine CaOx deposit burden.
A. The mean right (A), left (B) and combined mean (C) kidney bacterial burdens were lower with UPEC inoculation alone compared to kidneys with CaOx deposits and UPEC inoculation at 56,157±1.68X105 versus 2.14X106±3.34X106; 24,843±69,527 versus 4.50X106±7.83X106 and 40,500±1.12X105 versus 5.28X106±1.78X106 respectively. To present on a log scale graph, but not during statistical analysis, 0 values were assigned a value of 0.01 (D). Following glyoxalate injection, CaOx deposits are seen around the corticomedullary junction (arrows) (E) Following UPEC inoculation and glyoxalate injection, an increased distribution and number of CaOx deposits (arrows) is noted, extending into the medulla (arrowheads). D-E, representative 4X magnification image stitches, background cropped for clarity, scale bar = 1000μm. (F) CaOx deposit number per mean 4X imaging stitch cross-section area was significantly higher in the CaOx deposits and UPEC inoculation group compared to kidney stones alone. There was a higher percentage of CaOx deposit/total kidney cross section area (H) with CaOx deposits and UPEC than CaOx deposits alone. The location on the scatterplot for the representative images (D) and (E) are indicated by an arrowhead and arrow respectively.
Fig 5. PCR results.
Fig 5. PCR results.
(A) At peak murine CaOx deposit formation (6 days), the RT2 Bacterial Response Array revealed that 12/83 genes were significantly up-regulated > 4 fold. These genes included the inflammatory genes Chemokine (C-C motif) ligand 5 (Ccl5), Cluster of differentiation 14 (Cd14), Interleukin 1β (Il1b), Interleukin 6 (Il6), Lysozyme 2 (Lyz2), Mediterranean fever (Mefv), and Tumor necrosis factor (Tnf); the toll-like signaling genes, Interleukin–1 receptor-associated kinase 3 (Irak3) Toll-like receptor adaptor molecule 1 (Ticam1) and Toll-like receptor 2 (Tlr2) along with the inflammasome genes NLR family, apoptosis inhibitory protein 1 (Naip1) and NOD-like receptor family, pyrin domain containing 3 (Nlrp3). (B) In female C57Bl/6 mice, targeted RT-PCR revealed that at day 3 the inflammatory genes CD14 and Il6 are not increased in UPEC alone inoculated mice or CaOx alone inoculated mice compared to saline control, but are when both CaOx deposits and UPEC inoculation are present. (C) Toll-like signaling genes: Tlr2 followed a similar pattern to the inflammatory genes while Irak3 was not increased at day 3. (D) The inflammasome genes were not up-regulated at 3 days in any of the groups (E) Stone matrix protein inner core components were markedly up-regulated, but only when both CaOx deposits and UPEC inoculation were present.
Fig 6. Speculated mechanisms for bacterial contribution…
Fig 6. Speculated mechanisms for bacterial contribution to CaOx stones.
(A) Figure key. (B) Bacteria bind to CaOx crystals that may provide a nidus for pyelonephritis or remain persist in a subclinical state (1) and bacterial communities form a biofilm (2). The biofilm results in crystal aggregation (3). (C) The bacterial enzymes citrate lyase splits citrate resulting in increased CaOx supersaturation (1). CaOx crystals form providing a key element of lithogenesis. (D) Bacteria bind to the urothelium (1) that results in secretion of innate immune proteins from recruited inflammatory cells (2) and the urothelium (3) The innate immune proteins are incorporated as stone matrix proteins.

References

    1. Pak CY. Kidney stones. Lancet. 1998;351(9118):1797–801. Epub 1998/06/23. doi: S0140-6736(98)01295-1 [pii] 10.1016/S0140-6736(98)01295-1 .
    1. Lieske JC, Pena de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, et al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney international. 2006;69(4):760–4. Epub 2006/03/07. doi: 5000150 [pii] 10.1038/sj.ki.5000150 .
    1. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney international. 2001;59(6):2290–8. Epub 2001/05/31. doi: kid746 [pii] 10.1046/j.1523-1755.2001.00746.x .
    1. Flannigan R, Choy WH, Chew B, Lange D. Renal struvite stones–-pathogenesis, microbiology, and management strategies. Nature reviews Urology. 2014;11(6):333–41. Epub 2014/05/14. 10.1038/nrurol.2014.99 .
    1. Hugosson J, Grenabo L, Hedelin H, Lincolon K, Pettersson S. Chronic urinary tract infection and renal stones. Scandinavian journal of urology and nephrology. 1989;23(1):61–6. Epub 1989/01/01. .
    1. Holmgren K, Danielson BG, Fellstrom B, Ljunghall S, Niklasson F, Wikstrom B. The relation between urinary tract infections and stone composition in renal stone formers. Scandinavian journal of urology and nephrology. 1989;23(2):131–6. Epub 1989/01/01. .
    1. Wang X, Krambeck AE, Williams JC Jr., Tang X, Rule AD, Zhao F, et al. Distinguishing Characteristics of Idiopathic Calcium Oxalate Kidney Stone Formers with Low Amounts of Randall's Plaque. Clinical journal of the American Society of Nephrology: CJASN. 2014;9(10):1757–63. Epub 2014/08/06. 10.2215/CJN.01490214
    1. Tavichakorntrakool R, Prasongwattana V, Sungkeeree S, Saisud P, Sribenjalux P, Pimratana C, et al. Extensive characterizations of bacteria isolated from catheterized urine and stone matrices in patients with nephrolithiasis. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association. 2012;27(11):4125–30. Epub 2012/03/31. 10.1093/ndt/gfs057 .
    1. Grover RK, Cheng J, Peng Y, Jones TM, Ruiz DI, Ulevitch RJ, et al. The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(16):6036–41. 10.1073/pnas.1202214109
    1. Kaijser B, Hanson LA, Jodal U, Lidin-Janson G, Robbins JB. Frequency of E. coli K antigens in urinary-tract infections in children. Lancet. 1977;1(8013):663–6. .
    1. Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C, et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014;5(4):e01283–14. Epub 2014/07/10. 10.1128/mBio.01283-14
    1. Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, Mueller ER, et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. Journal of clinical microbiology. 2014;52(3):871–6. 10.1128/JCM.02876-13
    1. Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M, et al. Evidence of uncultivated bacteria in the adult female bladder. Journal of clinical microbiology. 2012;50(4):1376–83. Epub 2012/01/27. 10.1128/JCM.05852-11
    1. Srivastava T, Winston MJ, Auron A, Alon US. Urine calcium/citrate ratio in children with hypercalciuric stones. Pediatric research. 2009;66(1):85–90. 10.1203/PDR.0b013e3181a2939e .
    1. Cameron MA, Sakhaee K, Moe OW. Nephrolithiasis in children. Pediatr Nephrol. 2005;20(11):1587–92. 10.1007/s00467-005-1883-z .
    1. Grases F, Millan A, Conte A. Production of calcium oxalate monohydrate, dihydrate or trihydrate. A comparative study. Urol Res. 1990;18(1):17–20. Epub 1990/01/01. .
    1. Flythe JE, Rueda JF, Riscoe MK, Watnick S. Silicate nephrolithiasis after ingestion of supplements containing silica dioxide. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2009;54(1):127–30. 10.1053/j.ajkd.2008.10.042 .
    1. Osborne CA, Jacob F, Lulich JP, Hansen MJ, Lekcharoensul C, Ulrich LK, et al. Canine silica urolithiasis. Risk factors, detection, treatment, and prevention. The Veterinary clinics of North America Small animal practice. 1999;29(1):213–30, xiii. .
    1. Okada A, Nomura S, Higashibata Y, Hirose M, Gao B, Yoshimura M, et al. Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol Res. 2007;35(2):89–99. Epub 2007/03/30. 10.1007/s00240-007-0082-8 .
    1. Tittel AP, Heuser C, Ohliger C, Knolle PA, Engel DR, Kurts C. Kidney dendritic cells induce innate immunity against bacterial pyelonephritis. Journal of the American Society of Nephrology: JASN. 2011;22(8):1435–41. Epub 2011/07/16. 10.1681/ASN.2010101072
    1. Hains DS, Chen X, Saxena V, Barr-Beare E, Flemming W, Easterling R, et al. Carbonic anhydrase 2 deficiency leads to increased pyelonephritis susceptibility. American journal of physiology Renal physiology. 2014. Epub 2014/08/22. 10.1152/ajprenal.00344.2014 .
    1. Brubaker L, Wolfe AJ. The new world of the urinary microbiota in women. American journal of obstetrics and gynecology. 2015. 10.1016/j.ajog.2015.05.032 .
    1. Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract–-a role beyond infection. Nature reviews Urology. 2015;12(2):81–90. 10.1038/nrurol.2014.361 .
    1. Nacaroglu HT, Demircin G, Bulbul M, Erdogan O, Akyuz SG, Caltik A. The association between urinary tract infection and idiopathic hypercalciuria in children. Renal failure. 2013;35(3):327–32. 10.3109/0886022X.2013.764254 .
    1. Balestracci A, Battaglia LM, Toledo I, Martin SM, Wainsztein RE. Idiopathic hypercalciuria in children with urinary tract infection. Archivos argentinos de pediatria. 2014;112(5):428–33. 10.1590/S0325-00752014000500007 .
    1. Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, et al. Diversity of bacteria at healthy human conjunctiva. Investigative ophthalmology & visual science. 2011;52(8):5408–13. Epub 2011/05/17. 10.1167/iovs.10-6939
    1. Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, Kopecko DJ. An alternative interpretation of nanobacteria-induced biomineralization. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(21):11511–5. Epub 2000/10/12. 10.1073/pnas.97.21.11511
    1. Silva TM, Costa EA, Paixao TA, Tsolis RM, Santos RL. Laboratory animal models for brucellosis research. Journal of biomedicine & biotechnology. 2011;2011:518323 10.1155/2011/518323
    1. Velasco J, Romero C, Lopez-Goni I, Leiva J, Diaz R, Moriyon I. Evaluation of the relatedness of Brucella spp. and Ochrobactrum anthropi and description of Ochrobactrum intermedium sp. nov., a new species with a closer relationship to Brucella spp. International journal of systematic bacteriology. 1998;48 Pt 3:759–68. .
    1. Qasimyar H, Hoffman MA, Simonsen KA. Late-onset Ochrobactrum anthropi sepsis in a preterm neonate with congenital urinary tract abnormalities. Journal of perinatology: official journal of the California Perinatal Association. 2014;34(6):489–91. Epub 2014/05/30. 10.1038/jp.2014.31 .
    1. Wiessner JH, Henderson JD Jr., Sohnle PG, Mandel NS, Mandel GS. The effect of crystal structure on mouse lung inflammation and fibrosis. The American review of respiratory disease. 1988;138(2):445–50. 10.1164/ajrccm/138.2.445 .
    1. Fang HH, Chan KY, Xu LC. Quantification of bacterial adhesion forces using atomic force microscopy (AFM). Journal of microbiological methods. 2000;40(1):89–97. .
    1. Chutipongtanate S, Sutthimethakorn S, Chiangjong W, Thongboonkerd V. Bacteria can promote calcium oxalate crystal growth and aggregation. Journal of biological inorganic chemistry: JBIC: a publication of the Society of Biological Inorganic Chemistry. 2013;18(3):299–308. 10.1007/s00775-012-0974-0 .
    1. De Ferrari ME, Macaluso M, Brunati C, Pozzoli R, Colussi G. Hypocitraturia and Ureaplasma urealyticum urinary tract infection in patients with idiopathic calcium nephrolithiasis. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association. 1996;11(6):1185 Epub 1996/06/01. .
    1. Nilekani S, SivaRaman C. Purification and properties of citrate lyase from Escherichia coli. Biochemistry. 1983;22(20):4657–63. Epub 1983/09/27. .
    1. Ghazali A, Fuentes V, Desaint C, Bataille P, Westeel A, Brazier M, et al. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocr Metab. 1997;82(1):32–8. 10.1210/Jc.82.1.32 .
    1. Shoag J, Halpem J, Goldfarb D, Eisner B. Kidney Stones Are a Risk Factor for Ckd and Esrd. J Urology. 2014;191(4):E272–E. .
    1. Huang HS, Ma MC, Chen CF, Chen J. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology. 2003;62(6):1123–8. 10.1016/S0090-4295(03)00764-7 .
    1. Canales BK, Anderson L, Higgins L, Ensrud-Bowlin K, Roberts KP, Wu B, et al. Proteome of human calcium kidney stones. Urology. 2010;76(4):1017 e13-20. Epub 2010/08/17. 10.1016/j.urology.2010.05.005 .
    1. Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1beta secretion. The Journal of clinical investigation. 2013;123(1):236–46. Epub 2012/12/12. 10.1172/JCI63679
    1. Rhee E, Santiago L, Park E, Lad P, Bellman GC. Urinary IL–6 is elevated in patients with urolithiasis. J Urol. 1998;160(6 Pt 1):2284–8. Epub 1998/11/17. .
    1. Suen JL, Liu CC, Lin YS, Tsai YF, Juo SH, Chou YH. Urinary chemokines/cytokines are elevated in patients with urolithiasis. Urol Res. 2010;38(2):81–7. Epub 2010/03/06. 10.1007/s00240-010-0260-y .
    1. Mushtaq S, Siddiqui AA, Naqvi ZA, Rattani A, Talati J, Palmberg C, et al. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones. Clinica chimica acta; international journal of clinical chemistry. 2007;384(1–2):41–7. Epub 2007/07/06. 10.1016/j.cca.2007.05.015 .
    1. Lanter BB, Sauer K, Davies DG. Bacteria present in carotid arterial plaques are found as biofilm deposits which may contribute to enhanced risk of plaque rupture. mBio. 2014;5(3):e01206–14. Epub 2014/06/12. 10.1128/mBio.01206-14
    1. Gibson FC 3rd, Hong C, Chou HH, Yumoto H, Chen J, Lien E, et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2004;109(22):2801–6. Epub 2004/05/05. 10.1161/01.CIR.0000129769.17895.F0 .

Source: PubMed

3
Iratkozz fel